| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 223.03M | 210.13M | 202.98M | 233.33M | 275.97M | 411.65M |
| Gross Profit | 114.28M | 80.51M | 76.55M | 76.54M | 65.62M | 77.28M |
| EBITDA | 29.43M | 24.75M | 119.27M | 17.86M | -25.02M | -73.72M |
| Net Income | 119.24M | 123.54M | 91.06M | -7.38M | -85.86M | -113.33M |
Balance Sheet | ||||||
| Total Assets | 592.12M | 692.62M | 530.50M | 607.38M | 769.30M | 996.38M |
| Cash, Cash Equivalents and Short-Term Investments | 35.77M | 35.20M | 10.07M | 9.51M | 17.04M | 19.19M |
| Total Debt | 345.14M | 350.76M | 399.28M | 550.65M | 691.63M | 820.88M |
| Total Liabilities | 404.56M | 507.00M | 473.71M | 644.11M | 800.25M | 979.34M |
| Stockholders Equity | 187.55M | 185.62M | 56.79M | -36.73M | -30.95M | 17.05M |
Cash Flow | ||||||
| Free Cash Flow | 15.70M | 12.45M | -2.42M | -8.37M | -43.95M | -111.36M |
| Operating Cash Flow | 17.37M | 13.74M | -2.04M | -7.89M | -38.64M | -99.88M |
| Investing Cash Flow | -12.79M | -11.45M | 1.62M | 4.02M | 7.68M | -2.10M |
| Financing Cash Flow | 8.81M | 3.59M | 8.36M | -2.15M | 29.42M | 7.78M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | $4.17B | 16.47 | 91.16% | ― | 11.88% | 18.08% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | $69.60M | 0.64 | 98.54% | ― | 13.98% | 34.14% | |
58 Neutral | $16.83M | 5.82 | 48.22% | ― | 13.71% | ― | |
54 Neutral | $666.49M | 13.60 | 21.96% | 1.06% | 0.99% | 37.55% | |
46 Neutral | $300.81M | 0.27 | ― | ― | -9.32% | ― | |
44 Neutral | $123.98M | 539.71 | 0.12% | ― | -36.29% | -96.65% |
On October 28, 2025, Regis Corporation held its Annual Meeting of Shareholders, where several key proposals were voted on. The shareholders elected five director nominees for a one-year term, approved the advisory proposal on executive compensation, ratified the appointment of Grant Thornton LLP as the independent registered public accounting firm, approved the Amended and Restated 1991 Contributory Stock Purchase Plan, and ratified the extension of the Tax Benefits Preservation Plan.